Abstract:OBJECTIVE:The study was designed to investigate the changes in CD(69), CD(25) and HLA-DR expressions in peripheral blood T cell in Kawasaki disease (KD). METHODS:The authors detected CD(69), CD(25) and HLA-DR expressions in peripheral blood T cell by using flow cytometry. The patients who met the diagnostic criteria for KD comprised sixteen boys and fifteen girls (4 - 60 months of age; mean, 26 +/- 18 months). All received intravenous gammaglobulin at a dose of 1 g/(kg.d), for 2 days and oral aspirin at a dose of 30 - 50 mg/(kg.d). In case of persistent fever, a repeated dose of intravenous gammaglobulin or I.V. methylprednisolone at a dose of 20 mg/(kg.d) for three daily doses was attempted. The authors tested blood samples from 17 healthy controls consisting of nine boys and eight girls (3 - 84 months of age; mean, 25 +/- 18 months) and the samples from 31 patients. RESULTS:The percentage of peripheral blood CD(3)(+) T lymphocyte was (54.4 +/- 9.0)% in acute stage of KD and (65.0 +/- 7.0)% in healthy controls. There was a significant difference between the two groups (P < 0.001). The values of CD(69)(+) [(11.2 +/- 12.6)%, vs. (0.6 +/- 0.4)%], CD(25)(+) [(9.2 +/- 3.5)% vs. (3.9 +/- 1.8)%] and HLA-DR(+) [(8.3 +/- 5.0)% vs. (4.3 +/- 2.3)%] in KD patients were markedly increased compared to those of the healthy controls. After intravenous gammaglobulin treatment, the percentage of CD(3)(+)CD(69)(+) and CD(3)(+)CD(25)(+) significantly decreased [CD(3)(+)CD(69)(+): (14.0 +/- 13.0)% vs. (1.6 +/- 1.2)%, P < 0.05; CD(3)(+)CD(25)(+): (7.8 +/- 4.1)% vs. (2.0 +/- 0.6)%, P < 0.01]. However, the CD(3)(+) T lymphocytes increased [(50.8 +/- 5.0)% vs. (64.9 +/- 5.5)%, P < 0.01]. There was no significant difference in expression of CD(3)(+) T lymphocyte cell activating markers between coronary artery disease group and normal coronary artery group in KD cases (P > 0.05). CONCLUSION:CD(3)(+) T cell activation in the early and middle stages is involved in the mechanism responsible for cardiovascular injury.

Influence of Interleukin 18 Promoter Polymorphisms in Susceptibility to Kawasaki Disease in Taiwan.

The Roles of Ca 2+ /NFAT Signaling Genes in Kawasaki Disease: Single- and Multiple-Risk Genetic Variants

Systematic Confirmation Study of GWAS-identified Genetic Variants for Kawasaki Disease in a Chinese Population.

8P22-23-rs2254546 As a Susceptibility Locus for Kawasaki Disease: a Case-Control Study and a Meta-Analysis.

A genetic variant rs1801274 in FCGR2A as a potential risk marker for Kawasaki disease: a case-control study and meta-analysis.

The Network of Pro-Inflammatory Factors CD147, DcR3, and IL33 in the Development of Kawasaki Disease.

A functional polymorphism, rs28493229, in ITPKC and risk of Kawasaki disease: an integrated meta-analysis

Association of Polymorphisms in the IL‐10 Promoter Region with Crohn's Disease

Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease

Changes in CD_(69),CD_(25) and HLA-DR Expressions in Peripheral Blood T Cells in Kawasaki Disease

Association of Vascular Endothelial Growth Factor C–634 G Polymorphism in Taiwanese Children with Kawasaki Disease

The IL-1B Gene Polymorphisms rs16944 and rs1143627 Contribute to an Increased Risk of Coronary Artery Lesions in Southern Chinese Children with Kawasaki Disease

Inflammatory Gene Polymorphisms And Susceptibility To Kawasaki Disease And Its Arterial Sequelae

Disease Association of the Interleukin-18 Promoter Polymorphisms in Taiwan Chinese Systemic Lupus Erythematosus Patients

Association of Col11a2 Polymorphism with Susceptibility to Kawasaki Disease and Development of Coronary Artery Lesions

Single-nucleotide Polymorphism rs2290692 in the 3′UTR of ITPKC Associated With Susceptibility to Kawasaki Disease in a Han Chinese Population

Association of interleukin-18 gene polymorphisms with Takayasu arteritis in a Chinese Han population

Hla-E Gene Polymorphism Associated With Susceptibility To Kawasaki Disease And Formation Of Coronary Artery Aneurysms

ITPKC polymorphism (rs7251246 T > C), coronary artery aneurysms, and thrombosis in patients with Kawasaki disease in a Southern Han Chinese population

Evaluation Of Intravenous Immunoglobulin Resistance And Coronary Artery Lesions In Relation To Th1/Th2 Cytokine Profiles In Patients With Kawasaki Disease

Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease